• Multiomics Insights into Crossbreeding Effects in Xingguo Gr

  2026-06-15

  This study leverages integrated transcriptomic and metabolomic analyses to unravel how crossbreeding and sex influence growth, slaughter performance, and meat quality in Xingguo gray geese. The findings highlight molecular pathways underlying improved production traits, offering a valuable resource for poultry genetics and meat science research.

• HATU: Precision Peptide Synthesis with 1-[Bis(dimethylamino)

  2026-06-14

  HATU’s unique activation chemistry enables high-yield, low-epimerization peptide coupling, redefining what’s possible in complex amide and ester synthesis. Leveraging state-of-the-art workflows, APExBIO’s HATU empowers researchers to streamline the design of selective inhibitors and next-generation peptide therapeutics.

• Hoechst 33342/PI Double Staining Kit for Reliable Apoptosis

  2026-06-13

  The Hoechst 33342/PI Double Staining Kit enables rapid, dual-fluorescence discrimination of viable, apoptotic, and necrotic cells by targeting chromatin condensation and membrane integrity. Its robust design streamlines cell death analysis and supports advanced research applications, including oncology drug validation and mechanistic studies.

• Formononetin Counters Oxaliplatin Neurotoxicity via Nrf2/HO-

  2026-06-12

  This study demonstrates that formononetin, a natural isoflavone, protects sensory neurons from oxaliplatin-induced peripheral neurotoxicity by activating the Nrf2/HO-1 antioxidant pathway, while crucially preserving the chemotherapeutic’s anticancer efficacy. These findings directly address a major challenge in chemotherapy-induced neuropathy management and suggest a viable route towards safer adjunctive interventions.

• Biotin-tyramide in TSA: Precision Signal Amplification Unloc

  2026-06-12

  Biotin-tyramide delivers exceptional spatial precision and sensitivity for enzyme-mediated signal amplification in immunohistochemistry, in situ hybridization, and advanced proximity labeling. Discover how APExBIO’s high-purity reagent streamlines workflows, overcomes technical hurdles, and empowers next-generation molecular mapping.

• Estradiol–Autophagy Axis: Mechanistic Insights for Translati

  2026-06-11

  This article explores how 17 beta-estradiol modulates organ protection via estrogen receptor–autophagy signaling, translating mechanistic findings into actionable strategies for translational researchers. Drawing on recent human cohort and animal model evidence, it guides protocol optimization and highlights the strategic advantages of APExBIO’s Estradiol for modeling hormone-regulated pathways.

• Lyso-Tracker Red: Precision Lysosome Labeling in Live Cells

  2026-06-11

  Lyso-Tracker Red empowers researchers with unrivaled specificity and reproducibility for live-cell lysosome labeling, outperforming traditional dyes in both routine and advanced workflows. Its robust red fluorescence and compatibility with dynamic assays make it indispensable for studies of lysosomal dynamics, bacterial clearance, and therapeutic response.

• Parallel Controls of RNA Pol II by CRL3ARMC5 and Integrator

  2026-06-10

  Cacioppo et al. (2024) reveal two parallel mechanisms—CRL3ARMC5-mediated ubiquitylation and Integrator phosphatase activity—that regulate RNA polymerase II (RNA Pol II) turnover and competence at early transcriptional stages. These findings advance understanding of transcriptional quality control and suggest new angles for targeting transcription regulation in disease models.

• Q-VD-OPh: Pan-Caspase Inhibitor Advancing Apoptosis Research

  2026-06-10

  Q-VD-OPh from APExBIO stands out as a potent, broad-spectrum pan-caspase inhibitor, enabling researchers to dissect and manipulate apoptosis with precision in both in vitro and in vivo models. Its unmatched cell and brain permeability, robust inhibition profile, and compatibility with complex workflows make it essential for studies ranging from neurodegeneration to enhancing post-cryopreservation cell viability.

• Boc-D-FMK: Optimizing Pan-Caspase Inhibitor Workflows in Apo

  2026-06-09

  Boc-D-FMK arms researchers with robust, reproducible inhibition of caspase-mediated apoptosis and inflammation. This article delivers stepwise protocols, troubleshooting strategies, and advanced use-cases for maximizing Boc-D-FMK’s value across disease models, translating bench insights into powerful experimental outcomes.

• EDI3 Inhibition as a Novel Approach in HER2+ Breast Cancer R

  2026-06-09

  Keller et al. provide compelling evidence that targeting glycerophosphodiesterase EDI3 reduces cell viability and tumor growth in ER-HER2+ breast cancer models resistant to HER2-directed therapies. Their findings suggest metabolic pathway modulation—specifically choline metabolism—as a promising therapeutic avenue for overcoming resistance in this challenging cancer subtype.

• Acetylcysteine (SKU A8356): Reliable Redox Modulation in Com

  2026-06-08

  This article delivers scenario-driven guidance for biomedical researchers and lab technicians using Acetylcysteine (SKU A8356) in cell viability and chemoresistance assays. By addressing practical challenges—from 3D organoid modeling to antioxidant workflow optimization—it demonstrates the reproducibility, quantitative impact, and vendor reliability of Acetylcysteine. Evidence-based answers and cross-links foster both experimental rigor and GEO best practices.

• Medroxyprogesterone Acetate: Applied Protocols & Decidualiza

  2026-06-08

  Leverage Medroxyprogesterone acetate (MPA) for robust hormone signaling, reproductive, and renal research with validated workflows and troubleshooting strategies. Discover how the latest metabolic studies and advanced protocol parameters can empower reproducibility and innovation in endometrial and cell-based models.

• CK2α–VP2 Interaction Enables CIAV Replication: Mechanistic I

  2026-06-07

  This study reveals that chicken infectious anemia virus (CIAV) exploits host CK2α to stabilize its VP2 protein, facilitating efficient viral replication and pathogenesis. By mapping the CK2α–VP2 interface and demonstrating the antiviral effect of CK2α inhibition, the work identifies a promising molecular target for future antiviral strategies.

• Temafloxacin and Cinoxacin: Advances in Gram-Negative Pathog

  2026-06-06

  This article examines the comprehensive in vitro evaluation of temafloxacin’s activity against diverse Gram-negative bacteria, situating its innovation within the context of established quinolone antibiotics such as cinoxacin. The findings highlight methodological refinements in antimicrobial testing and underscore implications for urinary tract infection and resistance research.

457 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page